Category

Cancer and Cell Biology

Breast CancerCancer and Cell BiologyCancer EpigeneticsDisease AreaLabNews & EventsResearchResearch Area

Personalised medicine using nanoparticles for breast cancer treatment

By | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area

At the Harry Perkins Institute of Medical Research, a Cancer Epigenetics team is investigating ways to leverage the great opportunities that nanotechnology offers in the treatment of one of the…

Cancer and Cell BiologyDisease AreaLabNews & EventsResearchResearch AreaTumoursVascular Biology and Stromal Targeting

New collaboration to aid the development of drugs to treat cancers

By | Cancer and Cell Biology, Disease Area, Lab, News & Events, Research, Research Area, Tumours, Vascular Biology and Stromal Targeting

Cancer immunotherapies, including checkpoint blocking antibodies such as MSD’s Keytruda, have shown remarkable results in a number of different cancer types. However the effectiveness of these treatments may be enhanced…

CancerCancer and Cell BiologyDisease AreaGenesLabNews & EventsResearchResearch AreaSystems Biology and Genomics

Ground-breaking new study doubles the estimate of our functional genes

By | Cancer, Cancer and Cell Biology, Disease Area, Genes, Lab, News & Events, Research, Research Area, Systems Biology and Genomics

The findings, published in Nature, were the latest work of the FANTOM5 consortium, a group of researchers from Japan and Australia led by Professor Alistair Forrest from the Perkins and The University of…

Cancer and Cell BiologyCancer EpigeneticsDisease AreaLabNews & EventsResearchResearch AreaTumours

Perkins researchers turn on cancer killing genes

By | Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area, Tumours

Dr Benjamin Garcia Bloj, along with his labmates from the Perkins Cancer Epigenetics Laboratory headed by Associate Professor Pilar Blancafort, used a gene-editing technology called CRISPR to ‘wake up’ key tumour suppressors to…